Erin Furr Stimming MD, FAANProfessor, Neurology, and Memorial Hermann Endowed Chair, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, Texas; Huntington Study Group KINECT-HD Principal Investigator
Dr. Furr Stimming is a Professor of Neurology and Memorial Hermann Chair at the University of Texas Health Science Center at Houston, McGovern Medical School and a Fellow of the American Academy of Neurology. She is the Founder and Director of the Huntington’s Disease Society America (HDSA) Center of Excellence HD clinic at UTHealth, McGovern Medical School. She serves as the Neurology Clerkship Director and has received the Dean’s Excellence in Teaching award every year since 2009.
She has received the Dupont Master Clinical Teaching Award and most recently, she received the prestigious Leonard Tow Award in Humanism and Excellence in Teaching. She is a member of the Academy of Master Educators and a McGovern Society leader. She has been named a Super Doctor by Texas Monthly and a Top Doctor by Houstonia magazine for multiple years. She received her medical degree from The Chicago Medical School in 2003 and completed her post graduate training, including a neurology residency and Movement Disorders fellowship at The University of Texas Health Science Center at Houston.
Dr. Furr Stimming is actively engaged with the Parkinson’s and Huntington’s disease community. She is the Chair of the Medical Advisory Board for the Houston Area Parkinson’s Society and a member of local HDSA affiliate and frequently volunteers for both nonprofit organizations.
She is currently the President of the Houston Neurologic Society and Chair of the Texas Neurological Society Education Committee. She is the Co-Chair for the HSG Publication and Provider Education Committee. Dr. Furr Stimming is passionate about advancing care for individuals living with neurodegenerative disease, particularly Huntington’s and Parkinson’s disease.
Dr. Furr Stimming has received honoraria as an advisory board member, consulted for, received research funding from, and served on the speakers’ bureau for Cures Within Reach, the Cure Huntington's Disease Initiative, Huntington's Disease Society of America, Neurocrine Biosciences, Prilenia, Roche/Genentech, UniQure, Novartis, Teva Pharmaceuticals, Vaccinex, Sage Therapeutics and Sunovion.